Zipper-interacting protein kinase (ZIPK) is a widely expressed serine/threonine kinase that has been implicated in cell death and transcriptional regulation, but its mechanism of regulation remains unknown. Here, we identified threonine-265 (Thr265) in ZIPK as a major autophosphorylation site. Mutational analyses revealed that autophosphorylation of Thr265 was essential for its full catalytic activity toward an exogenous substrate as well as for cell death induction. Furthermore, leukemia inhibitory factor (LIF) stimulated Thr265 phosphorylation of ZIPK, thereby leading to phosphorylation and activation of signal transducer and activator of transcription (STAT3). Taken together, our findings demonstrate that ZIPK is positively regulated through Thr265 phosphorylation and that this phosphorylation is essential for its function.
Introduction
Zipper-interacting protein kinase (ZIPK) was originally identified as a binding partner of activating transcription factor 4 (ATF4), a member of the activating transcription factor/cyclic AMP-responsive element binding family of transcription factor proteins [1, 2] . ZIPK aggregates through its C-terminal leucine zipper (LZ) structure, thereby becoming an active enzyme. Ectopic expression of ZIPK in NIH 3T3 cells induced apoptosis. In contrast, a kinase-inactive mutant protein, ZIPK K42A, failed to induce apoptosis, indicating that ZIPK stimulates apoptosis via its catalytic activity [1] . The kinase domain of ZIPK shows strong homology to that of death-associated protein kinase (DAPK). ZIPK and DAPK constitute members of a family of related kinases that includes DAPK2/DRP-1, DRAK1 and DRAK2 [3] [4] [5] [6] [7] [8] , all of which have been implicated in the execution of apoptosis. Introduction of a DAPK antisense was shown to block interferon (IFN)-γ-induced apoptosis in HeLa cells [9] , indicating that DAPK is required for IFN-γ-induced cell death. Furthermore, evidence that the DAPK may function as a tumor suppressor was provided [10, 11] . Previous studies showed that ZIPK, in collaboration with Daxx and Par-4, induced apoptosis 4 from nuclear promyelocytic leukemia protein (PML) oncogenic domains (PODs) [12] .
However, the mechanisms responsible for the activation of these kinases and the downstream substrates that mediate their apoptotic activities remain unknown. Recently, we have demonstrated that ZIPK interacts physically with STAT3 [13] . ZIPK specifically interacted with STAT3, and did not bind to STAT1, STAT4, STAT5a, STAT5b or STAT6. ZIPK phosphorylated STAT3 on serine-727 (Ser727) and enhanced STAT3 transcriptional activity. Small-interfering RNA-mediated reduction of ZIPK expression decreased LIF-and IL-6-induced STAT3-dependent transcription.
Furthermore, LIF-and IL-6-mediated STAT3 activation stimulated ZIPK activity.
In the present study, we identified threonine-265 (Thr265) as an autophosphorylation site of ZIPK, and found that Thr265 phosphorylation was critical for both kinase activation and cell death induction. Furthermore, mutation of Thr265 suppressed ZIPK-mediated enhancement of IL-6-induced STAT3 activation. In addition, LIF stimulated Thr265 phosphorylation, suggesting that IL-6/LIF signaling mediates ZIPK activation through phosphorylation of Thr265.
Materials and Methods

Reagents, antibodies, Glutathione S-transferase (GST)-fusion proteins and peptides.
Human recombinant IL-6 was a gift from Ajinomoto (Tokyo, Japan). Human recombinant LIF was purchased from INTERGEN (Purchase, NY). Expression vectors for epitope-tagged ZIPK, ZIPK kinase domain(KD), DAPK2, DRAK1, DRAK2 and DAPK KD were described previously [1, 4, 7, 13] . Expression vectors for STAT3-LUC [14] was kindly provided by Dr. T. Hirano (Osaka Univ. Med. Sch., Osaka, Japan), respectively. Epitope-tagged ZIPK mutant constructs (ZIPK KD T265A, ZIPK KD S269A, ZIPK KD S273A and ZIPK T265A) were generated by PCR and sequenced (primer sequences are available upon request). Anti-Myc and anti-GST antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-FLAG M2 monoclonal antibody was purchased from Sigma (St Louis, MO). To obtain recombinant GST -fusion ZIPK proteins, the full-length or mutant cDNA of ZIPK was inserted in frame into pGEX4 vector. Recombinant proteins were expressed in 6 Escherichia coli (E. coli) DH5α. The cells were grown for 6 h at 37 °C, and the protein was induced with 1µM isopropyl-β-D-thiogalactopyranoside (IPTG) at 30 °C for 15 h. Rat hepatoma cell line H35 was maintained in DMEM containing 10 % FCS [13] .
Stable H35 transformants expressing empty vector (pcDNA3), Myc-ZIPK WT or Myc-ZIPK T265A were established as described previously [1, 13] and comparable protein expression of Myc-ZIPK was confirmed by immunoblotting by anti-Myc antibody (data not shown). H35 cells were maintained in the presence of G418 (0.5 mg/ml) and transfected with STAT3-LUC using Metafectene (Biontex Laboratories GmbH, München, Germany) according to the manufacturer's instructions. Thirty hours after transfection, the cells were treated with IL-6 for 12 h. The cells were harvested and assayed for the luciferase activity using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI) according to the manufacturer's instructions. At least three independent experiments were carried out for each assay. Human embryonic kidney carcinoma cell line, 293T, was maintained in DMEM containing 10 % FCS and transfected by the standard calcium precipitation protocol [15] .
3. Immunoprecipitation, immunoblotting and in vitro phosphorylation.
The immunoprecipitation and immunobloting were performed as described previously [16] . The cells were harvested and lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1 % NP-40, 1 µM sodium orthovanadate, 1 µM phenylmethylsulfonyl fluoride and 10 µg/ml each of aprotinin, pepstatin and leupeptin).
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The immunoprecipitates from cell lysates were resolved on SDS-PAGE and transferred to Immobilon filter (Millipore; Bedford, MA). The filters were then immunoblotted with relevant antibodies. Immunoreactive proteins were visualized using an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech). In vitro kinase reactions were preformed as described [1, 17] . Briefly, immune complex of ZIPK was 
4. Cell death assay.
Cell death assay was performed as described previously [1] . Briefly, mouse NIH 3T3
cells were seeded at a density of 10 6 cells/100-mm dish in DMEM containing 10% FCS.
Cells were transfected with various plasmids in combination with pEGFP (Clontech). showed no 32 P incorporation (Fig. 1E) . These results suggest that there are major autophosphorylation sites between residues 157 and 275 in the C-terminal region of the ZIPK kinase domain.
To further narrow down the candidate autophosphorylation sites, we performed in vitro kinase assays on synthetic peptides of sequences present in the kinase domain. A total of 10 peptides (Pep#1-Pep#10) that contained serine (Ser) or Thr residues in the kinase domain were synthesized ( Fig. 2A and B) . All the synthetic peptides were successfully separated by SDS-PAGE and silver-stained (Fig. 2C ). The synthetic peptides were then in vitro phosphorylated in the presence of GST or GST-ZIPK and separated by SDS-PAGE (Fig. 2B) , followed by autoradiography. Notably, Pep#9, which contained one threonine residue (Thr265) and two serine residues (Ser269 and Ser273), was markedly phosphorylated by GST-ZIPK in vitro.
2. Thr265 in ZIPK is critical for its kinase activation
To confirm that Thr265 and Ser269/273 are autophosphorylation sites in ZIPK, we tested the kinase activity of ZIPK using deletion mutants that only encoded the kinase domain (ZIPK KD) with specific substitutions of each of these residues (T265A, S269A
and S273A) (Fig. 3A) . ZIPK KD, T265A, S269A or S273A was transiently expressed in (Fig. 3F) . These results suggest that Thr265 in ZIPK is required for its ability to mediate cell death, and strongly suggest that autophosphorylation of Thr295 of ZIPK plays an important role in the induction of cell death.
4. Thr265 in ZIPK is important for ZIPK-mediated enhancement of STAT3 activation
Next, we measured the effect of Thr265 on ZIPK-mediated enhancement of STAT3 activation using reporter assays. The STAT3-mediated transcriptional responses were measured by using STAT3-LUC, in which the α2-macroglobulin promoter [13, 14] drives expression of the LUC gene. antibody. The expressions of wild-type ZIPK and ZIPK T265A were comparable when confirmed by immunoblotting with an anti-FLAG-antibody (Fig. 4B, bottom panels) .
When the lysates were blotted with the anti-pZIPK Thr265 antibody, wild-type ZIPK, but not ZIPK T265A, was recognized (Fig. 4B, upper panels) .
Next, we examined whether Thr265 is phosphorylated in response to stimuli.
Wild-type ZIPK-or ZIPK T265A-transfected 293T cells were stimulated with LIF. The cell lysates were analyzed by immunoblotting with the anti-pZIPK Thr265 or anti-FLAG antibodies. Phosphorylation of Thr265 was only detected in wild-type ZIPK-transfected 293T cells (Fig. 4C) . Furthermore, its phosphorylation was remarkably enhanced by LIF stimulation. Blotting with the anti-FLAG antibody confirmed equal loading. These results clearly demonstrate that ZIPK is phosphorylated at Thr265 in response to LIF. IL-6 also stimulated ZIPK autophosphorylation (data not shown).
6. Concluding remarks
During the preparation of this manuscript, a report describing the identification of several ZIPK autophosphorylation sites was published [18] . In that report, Thr180, Thr225, Thr265, Thr299, Ser306 and Ser311 in ZIPK were phosphorylated in vivo.
These data support that the C-terminal domain of ZIPK T265A is still phosphorylated in 293T cells as shown in Fig. 3C . Furthermore, phosphorylation of three sites within the kinase domain (Thr180, Thr225 and Thr265) was shown to be required for its kinase activity, which is consistent with our data on Thr265. Similarly, these ZIPK mutants T180A, T225A, and T265A have been also shown to lose ZIPK cell death activity.
Our present study provides evidence that Thr265 in ZIPK is an autophosphorylation site that is essential for its full kinase activity. Phosphorylation of Thr265 is also important for ZIPK-mediated cell death and the enhancement of IL-6-induced STAT3 activation. We have further clarified that LIF induces phosphorylation of Thr265 in 293T cells using an anti-pZIPK Thr265 antibody. STAT3 is mainly activated by the IL-6
family of cytokines, epidermal growth factor and leptin [19] [20] [21] . Similar to other members of the STAT family, STAT3 is tyrosine-phosphorylated by Janus kinases (Jaks), which induce its dimerization and translocation into the nucleus where it activates its target genes [22, 23] . STAT3 is known to play crucial roles in early embryonic development as well as in other biological responses including cell growth and apoptosis [20, 24] . Furthermore, it is constitutively activated in oncogenic tyrosine kinase v-src-or v-abl-transformed cells and various primary tumors and cell lines [25, 26] . Recently, we demonstrated that IL-6/LIF-mediated STAT3 activation enhanced ZIPK activity [13] . This finding may suggest that IL-6/LIF/STAT3 signaling mediates apoptotic activity by stimulating ZIPK. 
